-
FDA Approves Precision Solid Tumor Cancer Diagnostics
The Food and Drug Administration approved genomic tests for solid tumor cancers that identify the most promising available therapies matched to the tumor’s genetic mutations.
-
Drug Price Report Calls for Govt Negotiation, More Generics
A panel convened by the National Academies calls for the federal government to use its buying power to negotiate better drug prices for consumers.
-
Four Signs You’re Not Ready To Start A Business (Yet)
Understanding whether or not you’re truly prepared for the task of running your own business is difficult; you have never done this before, so you don’t realistically know what to expect.
-
FDA Clears Smart Watch EKG Device
The Food and Drug Administration approved an electrocardiogram, or EKG device, designed to work with Apple smart watches, according to AliveCor, developer of the device.
-
RNA Injections Shown to Rebuild Damaged Heart Muscle
Engineers and medical researchers developed a technique to deliver genetic material into damaged heart muscle that in lab mice regrows heart cells.
-
Protein Made by Synthetic Bacteria with Expanded DNA
An academic-industry lab team produced a synthetic protein from an engineered bacteria, with DNA modified to expand its number of chemical coding components.
-
Marine Animal Venom Studied for Pain Drugs
A medical research team is investigating the chemistry in venom from snail-like marine animals to discover natural alternative drugs for pain.
-
Artificial Muscles Designed for Soft Robotics
Engineering researchers created artificial muscles for robotics using principles from origami, or Japanese paper folding, with high strength and low-cost materials.
-
Survey: More Research Patents, Start-Ups in 2016
A survey of universities and other institutions shows the number of patent filings and new start-up companies resulting from federally-funded research climbed in 2016.
-
Trial to Test Ultrasound/MRI for Brain Cancer
A developer of a technology that combines ultrasound and MRI scans plans to begin a clinical trial of its techniques to improve delivery of drugs to treat a form of brain cancer.